This year's American Society for Clinical Oncology (ASCO)
conference is over and as 45,000 scientists head home,
DrugResearcher.com looks at some of the most innovative drugs that
were on show.
A study suggesting combination therapy could stop the spread and
halt the growth of skin melanomas could pave the way for a better
understanding of the disease, and thus, the development of more
effective long-term treatment options...